Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Zornberg

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|November 10, 2000
Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control studyG L Zornberg, H Jick
Journal of Clinical Psychopharmacology|December 1, 1993
Treatment of depression in bipolar disorder: new directions for researchG L Zornberg, H G Pope
Schizophrenia Bulletin|July 8, 2000
The problem of obstetrical complications and schizophreniaG L Zornberg, S L Buka, M T Tsuang
The American Journal of Psychiatry|February 15, 2000
Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal studyG L Zornberg, S L Buka, M T Tsuang
Journal of Clinical Psychopharmacology|February 1, 1995
Buprenorphine treatment of refractory depressionJ A Bodkin, G L Zornberg, S E Lukas, et al.
Lancet (London, England)|November 23, 2000
Statins and the risk of dementiaH Jick, G L Zornberg, S S Jick, et al.
Archives of Neurology|March 20, 2001
Postmenopausal estrogen replacement therapy and the risk of Alzheimer diseaseS Seshadri, G L Zornberg, L E Derby, et al.
The Journal of Nervous and Mental Disease|May 1, 1996
Treatment of negative symptoms in schizophrenia and schizoaffective disorder by selegiline augmentation of antipsychotic medication. A pilot study examining the role of dopamineJ A Bodkin, B M Cohen, M S Salomon, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|January 21, 2014
What and how psychiatry residents at ten training programs wish to learn about ethicsL W Roberts, T McCarty, C Lyketsos, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|November 10, 2000
Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control studyG L Zornberg, H Jick
Journal of Clinical Psychopharmacology|December 1, 1993
Treatment of depression in bipolar disorder: new directions for researchG L Zornberg, H G Pope
Schizophrenia Bulletin|July 8, 2000
The problem of obstetrical complications and schizophreniaG L Zornberg, S L Buka, M T Tsuang
The American Journal of Psychiatry|February 15, 2000
Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal studyG L Zornberg, S L Buka, M T Tsuang
Journal of Clinical Psychopharmacology|February 1, 1995
Buprenorphine treatment of refractory depressionJ A Bodkin, G L Zornberg, S E Lukas, et al.
Lancet (London, England)|November 23, 2000
Statins and the risk of dementiaH Jick, G L Zornberg, S S Jick, et al.
Archives of Neurology|March 20, 2001
Postmenopausal estrogen replacement therapy and the risk of Alzheimer diseaseS Seshadri, G L Zornberg, L E Derby, et al.
The Journal of Nervous and Mental Disease|May 1, 1996
Treatment of negative symptoms in schizophrenia and schizoaffective disorder by selegiline augmentation of antipsychotic medication. A pilot study examining the role of dopamineJ A Bodkin, B M Cohen, M S Salomon, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|January 21, 2014
What and how psychiatry residents at ten training programs wish to learn about ethicsL W Roberts, T McCarty, C Lyketsos, et al.
Pageof 1